Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Gold Nanoparticle-Based Assay Enables Rapid Detection of Dengue Virus

By LabMedica International staff writers
Posted on 08 Jul 2013
A rapid colorimetric agglutination assay for the detection of Dengue virus comprises reagents that are stable at room temperature and is sensitive and simple enough for field use.

The Dengue virus infects from 50-100 million people per year world-wide, and approximately 2.5% of infected individuals die from the disease, which has no vaccine or effective antiviral therapy. More...
The main method for preventing spread of the disease is through control of the mosquito vector.

Investigators at Notre Dame University (IN, USA) sought to develop a rapid assay to replace the laborious methods currently employed for detecting the virus in mosquito cells and cultures.

They described the development of an assay system based on gold nanoparticles (AuNPs) coated with a DNAzyme specific for the Dengue virus RNA genome. DNAzymes are DNA molecules that have the ability to perform a chemical reaction, such as catalytic action. In nature DNA is only associated only with gene replication. This is due to DNA's lacking the 2'-hydroxyl group of RNA, which diminishes its chemical reactivity and its ability to form complex tertiary structures, and that nearly all biological DNA exists in the double helix conformation in which potential catalytic sites are shielded. For these reasons, DNAzymes exist only in the laboratory.

When AuNPs coated with DNAzyme specific for Dengue virus RNA were introduced into cultures of Dengue-infected mosquito cells in the presence of magnesium and heat (37 degrees Celsius) the DNA-enzyme cleaved the viral RNA. This cleavage resulted in deshielding and aggregation of the AuNPs in the presence of NaCl, causing a visually detectable red to clear color transition that could be quantified by UV/Visible spectrophotometry at 520 nanometers wavelength. If Dengue viruses were not present in the sample, the DNAzyme-coated AuNPs remained in a dispersed state and no color loss occurred. Likewise, if any of the essential components such as magnesium or sodium were not present in the reaction mixture, no aggregation was possible. The inclusion of the detergent sodium dodecyl sulfate (SDS) in the reaction mixture permitted the detection of Dengue virus directly from cell culture supernatants without additional sample processing.

The assay was shown to be able to detect as few as 10 viruses in samples containing from 10-20 mosquitoes. Test components were stable above 30 degrees Celsius, which would allow for storage and transportation under field conditions.

First author Dr.James Carter, postdoctoral research associate at Notre Dame University, said, "Full development of our novel DNAzyme-AuNP detection method will provide a practical, rapid, and low cost alternative for the detection of Dengue virus in mosquito cells and tissues, and possibly infected patient serum, in a matter of minutes with little to no specialized training required."

Results from tests carried out with the AuNP detection system were published in the June 28, 2013, online edition of the Virology Journal.

Related Links:
Notre Dame University


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.